Table 6. Daily warfarin dose requirements based on gender in patients with various CYP2C9, VKORC1 and factor VII genotypes.

VKORC1: Vitamin K epoxide reductase genotype, CYP2C9*2: cytochrome P450 2C9*2 genotype, CYP2C9*3: cytochrome P450 2C9*3 genotype, factor VII: coagulation factor VII genotype, a: t-test, b: Mann-Whitney Test.